Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Csernansky

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Psychopharmacology|January 1, 1987
Differential effects of proglumide on mesolimbic and nigrostriatal dopamine functionJ G Csernansky, S Glick, J Mellentin
Biological Psychiatry|October 1, 1990
Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport systemM Jibson, K F Faull, J G Csernansky
Psychopharmacology|January 1, 1989
Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpirideE S Prosser, R Pruthi, J G Csernansky
Brain Research Bulletin|September 1, 1990
A microassay for measuring synaptosomal 3H-dopamine and 3H-metabolite releaseE C Petrie, L Lombrozo, J G Csernansky
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1990
Schizophrenia spectrum disorder and limbic epilepsyJ G Csernansky, D B Leiderman, J Goldman
Journal of Clinical Psychopharmacology|February 1, 1997
Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitorsY Sheline, M E Bardgett, J G Csernansky
Psychiatry Research|January 1, 1987
Rating scales in research: the case of negative symptomsS Thiemann, J G Csernansky, P A Berger
The American Journal of Psychiatry|October 1, 1993
Atropinism may precipitate neuroleptic malignant syndrome during treatment with clozapineD Nemecek, D Rastogi-Cruz, J G Csernansky
The American Journal of Psychiatry|September 1, 1986
Clonidine therapy in withdrawal from high-dose alprazolam treatmentS Vinogradov, A L Reiss, J G Csernansky
Psychiatry Research|September 1, 1988
Seasonal changes of CSF monoamine metabolites in psychiatric patients: what is the source?J G Csernansky, K F Faull, A Pfefferbaum
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Psychopharmacology|January 1, 1987
Differential effects of proglumide on mesolimbic and nigrostriatal dopamine functionJ G Csernansky, S Glick, J Mellentin
Biological Psychiatry|October 1, 1990
Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport systemM Jibson, K F Faull, J G Csernansky
Psychopharmacology|January 1, 1989
Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpirideE S Prosser, R Pruthi, J G Csernansky
Brain Research Bulletin|September 1, 1990
A microassay for measuring synaptosomal 3H-dopamine and 3H-metabolite releaseE C Petrie, L Lombrozo, J G Csernansky
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1990
Schizophrenia spectrum disorder and limbic epilepsyJ G Csernansky, D B Leiderman, J Goldman
Journal of Clinical Psychopharmacology|February 1, 1997
Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitorsY Sheline, M E Bardgett, J G Csernansky
Psychiatry Research|January 1, 1987
Rating scales in research: the case of negative symptomsS Thiemann, J G Csernansky, P A Berger
The American Journal of Psychiatry|October 1, 1993
Atropinism may precipitate neuroleptic malignant syndrome during treatment with clozapineD Nemecek, D Rastogi-Cruz, J G Csernansky
The American Journal of Psychiatry|September 1, 1986
Clonidine therapy in withdrawal from high-dose alprazolam treatmentS Vinogradov, A L Reiss, J G Csernansky
Psychiatry Research|September 1, 1988
Seasonal changes of CSF monoamine metabolites in psychiatric patients: what is the source?J G Csernansky, K F Faull, A Pfefferbaum
Pageof 14